EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum 25-Hydroxyvitamin D Levels and Youth-Onset Type 2 Diabetes: A Two-Sample Mendelian Randomization Study

Benjamin De La Barrera, Despoina Manousaki

Nutrients · 2023

DOI: 10.3390/nu15041016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Benjamin De La Barrera und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of the Sainte-Justine University Hospital, University of Montreal, Montreal, QC H3T 1C5, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Child Health Clinician Scientist Program (ENRICH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Observational studies have linked vitamin D insufficiency to pediatric type 2 diabetes (T2D), but evidence from vitamin D supplementation trials is sparse. Given the rising prevalence of pediatric T2D in all ethnicities, determining the protective role of vitamin D has significant public health importance. We tested whether serum 25-hydroxyvitamin D (25OHD) levels are causally linked to youth-onset T2D risk using Mendelian randomization (MR). We selected 54 single-nucleotide polymorphisms (SNPs) associated with 25OHD in a European genome-wide association study (GWAS) on 443,734 individuals and obtained their effects on pediatric T2D from the multi-ethnic PRODIGY GWAS (3006 cases/6061 controls). We applied inverse variance weighted (IVW) MR and a series of MR methods to control for pleiotropy. We undertook sensitivity analyses in ethnic sub-cohorts of PRODIGY, using SNPs in core vitamin D genes or ancestry-informed 25OHD SNPs. Multivariable MR accounted for the mediating effects of body mass index. We found that a standard deviation increase in 25OHD in the logarithmic scale did not affect youth-onset T2D risk (IVW MR odds ratio (OR) = 1.04, 95% CI = 0.96–1.13, p = 0.35) in the multi-ethnic analysis, and sensitivity, ancestry-specific and multivariable MR analyses showed consistent results. Our study had limited power to detect small/moderate effects of 25OHD (OR of pediatric T2D < 1.39 to 2.1). In conclusion, 25OHD levels are unlikely to have significant effects on the risk of youth-onset T2D across different ethnicities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HumansAdolescentChildRisk FactorsMendelian Randomization AnalysisGenome-Wide Association StudyVitamin DCalcifediolPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

GWASMendelian randomizationcausal inferencepediatric type 2 diabetesvitamin D

Substanzen

25-hydroxyvitamin DVitamin DCalcifediol

Autor:innen und Institutionen

  • Research Center of the Sainte-Justine University Hospital, University of Montreal, Montreal, QC H3T 1C5, Canada.
  • Departments of Pediatrics, Biochemistry and Molecular Medicine, University of Montreal, Montreal, QC H3T 1C5, Canada.

Förderung

  • Canadian Child Health Clinician Scientist Program (ENRICH)

Zitieren

APA

De La Barrera, B., & Manousaki, D. (2023). Serum 25-Hydroxyvitamin D Levels and Youth-Onset Type 2 Diabetes: A Two-Sample Mendelian Randomization Study. Nutrients. https://doi.org/10.3390/nu15041016

Vancouver

De La Barrera B, Manousaki D. Serum 25-Hydroxyvitamin D Levels and Youth-Onset Type 2 Diabetes: A Two-Sample Mendelian Randomization Study. Nutrients. 2023. doi:10.3390/nu15041016

BibTeX
@article{DeLaBarrera2023,
  author = {De La Barrera, Benjamin and Manousaki, Despoina},
  title = {Serum 25-Hydroxyvitamin D Levels and Youth-Onset Type 2 Diabetes: A Two-Sample Mendelian Randomization Study},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15041016}
}
Kostenlos starten →